Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsCisplatinPlatinum CompoundsEmployer Health CostsDoxorubicinDrug Resistance, NeoplasmChemotherapy, AdjuvantEtoposidePrescription FeesCell Line, TumorNeoplasmsOrganoplatinum CompoundsPaclitaxelDrug Screening Assays, AntitumorAntineoplastic Agents, PhytogenicOvarian NeoplasmsDrug Delivery SystemsCell SurvivalBreast NeoplasmsApoptosisCarboplatinCombined Modality TherapyFluorouracilTreatment OutcomeCyclophosphamideTumor Cells, CulturedDose-Response Relationship, DrugDisease-Free SurvivalNeoadjuvant TherapyGene Expression Regulation, NeoplasticLung NeoplasmsCell ProliferationNeoplasm StagingSurvival AnalysisDrug Administration ScheduleSurvival RatePrognosisTaxoidsVinblastineMethotrexateNeoplasm Recurrence, LocalDeoxycytidineIfosfamideInduction ChemotherapyCarcinoma, Non-Small-Cell LungAntimetabolites, AntineoplasticSalvage TherapyBleomycinNeoplasms, Glandular and EpithelialDNA AdductsAnthracyclinesFollow-Up StudiesAntineoplastic Agents, AlkylatingAdenocarcinomaNeutropeniaTesticular NeoplasmsTime FactorsNeoplasm MetastasisNauseaVomitingChemotherapy, Cancer, Regional PerfusionCytarabineBridged CompoundsPeritoneal NeoplasmsAntibiotics, AntineoplasticLeukopeniaClinical Trials as TopicInfusions, IntravenousKaplan-Meier EstimateTransplantation, AutologousColorectal NeoplasmsLymphoma, Non-HodgkinCamptothecinNeoplasms, Germ Cell and EmbryonalRadiotherapy, AdjuvantHodgkin DiseaseProspective StudiesCyclohexylaminesEmbolization, TherapeuticRadiotherapyCarcinomaInfusions, Intra-ArterialOsteosarcomaBrain NeoplasmsRecurrenceTumor Markers, BiologicalDacarbazineCoordination ComplexesBone NeoplasmsMitomycinCarmustineLomustineStomach NeoplasmsCarcinoma, Squamous CellGranulocyte Colony-Stimulating FactorAntibodies, Monoclonal, HumanizedLiver NeoplasmsThrombocytopeniaHyperthermia, Induced